Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy
Alberto Briganti, Jeffrey R. Karnes, L. Da Pozzo et al. · European Urology · 2008
Cited by 308 works. doi:10.1016/j.eururo.2008.09.043
Authors
- Alberto Briganti
- Jeffrey R. Karnes
- L. Da Pozzo
- C. Cozzarini
- Andrea Gallina
- Nazareno Roberto Suardi
- Marco Bianchi
- Massimo Freschi
- Claudio Doglioni
- Ferruccio Fazio
- Patrizio Rigatti
- Francesco Montorsi
- Michael L. Blute
References
- Detection of Organ-Confined Prostate Cancer Is Increased Through Prostate-Specific Antigen—Based Screening
- EAU Guidelines on Prostate Cancer
- Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
- Extended Pelvic Lymphadenectomy In Patients Undergoing Radical Prostatectomy: High Incidence Of Lymph Node Metastasis
- Judging New Markers by Their Ability to Improve Predictive Accuracy
- Re: Disease Progression and Survival of Patients With Positive Lymph Nodes After Radical Prostatectomy. Is There a Chance Of Cure?
- Is a Limited Lymph Node Dissection An Adequate Staging Procedure for Prostate Cancer?
- Disease Progression and Survival of Patients With Positive Lymph Nodes After Radical Prostatectomy. Is there a Chance of Cure?
- Risk of prostate carcinoma death in patients with lymph node metastasis
- IMPACT OF SEPARATE VERSUS EN BLOC PELVIC LYMPH NODE DISSECTION ON THE NUMBER OF LYMPH NODES RETRIEVED IN CYSTECTOMY SPECIMENS